BlackRock Health Sciences Opportunities Portfolio (SHSCX) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.66: the stock has moved about 34% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerBlackRock Health Sciences Opportunities Portfolio (SHSCX) trades at $47.34. BlackRock Health Sciences Opportunities Portfolio (SHSCX) is a mutual fund focused on investing in equity securities of companies within the health sciences and related industries. Sector: Financials.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for SHSCX: SHSCX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
BlackRock Health Sciences Opportunities Portfolio (SHSCX) Financial Services Profile
BlackRock Health Sciences Opportunities Portfolio (SHSCX) is a financial services fund with a $6.60 billion market cap, specializing in health sciences and related industries, including healthcare equipment, biotechnology, and pharmaceuticals. The fund concentrates its investments in these sectors, potentially including non-U.S. companies, and exhibits a beta of 0.66.
What Is the Investment Thesis for SHSCX?
The BlackRock Health Sciences Opportunities Portfolio (SHSCX) presents a focused investment in the growing health sciences sector. With a market capitalization of $6.60 billion and a beta of 0.66, the fund offers a targeted approach to capturing potential upside in healthcare equipment, biotechnology, and pharmaceuticals. The fund's strategy of concentrating investments in health sciences allows it to capitalize on sector-specific growth drivers, such as technological advancements and increasing healthcare demand. Key value drivers include the fund's ability to identify and invest in innovative companies within the health sciences sector, as well as its potential to benefit from favorable regulatory changes and demographic trends. The absence of a dividend yield suggests a focus on capital appreciation rather than income generation. A potential risk is the fund's concentration in a single sector, which could lead to increased volatility compared to a more diversified portfolio. The fund's performance is closely tied to the overall health of the health sciences industry and its ability to navigate regulatory and competitive challenges.
Based on FMP financials and quantitative analysis
SHSCX Key Highlights
The fund invests at least 80% of its total assets in equity securities of companies in health sciences and related industries, providing focused exposure to the sector.
- The health sciences sector includes companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals, offering diversified investment opportunities within the healthcare landscape.
- The fund concentrates its investments (i.e., invests more than 25% of its assets) in health sciences or related industries, indicating a high conviction in the sector's growth potential.
- The fund may invest in companies located in non-U.S. countries, providing global exposure to the health sciences sector.
- The fund has a market capitalization of $6.60 billion, reflecting its size and significance within the asset management industry.
Who Are SHSCX's Competitors?
SHSCX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| FSPHX Fidelity Select Health Care Portfolio | $29.89 | +1.81% | $6.96B | — |
| LMGNX ClearBridge International Growth I | $74.31 | -0.39% | $7.27B | — |
| MUTHX Mutual Shares Corporation Cl Z (Series of Franklin Mutual Ser Fd Inc.) | $26.94 | +0.60% | $6.60B | — |
| PRPFX Permanent Portfolio Class I | $77.34 | +0.35% | $7.33B | — |
| RBAIX T. Rowe Price Balanced I Class | $29.86 | +0.30% | $5.28B | — |
| BLK BlackRock, Inc. | $1080.38 | +1.31% | $165B | 51 5-pillar |
| BX Blackstone Inc. | $112.73 | +0.97% | $136B | 66 5-pillar |
| APOS Apollo Global Management, Inc. | $25.52 | -0.25% | $74.8B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SHSCX's Key Strengths?
Strong focus on the health sciences sector.
- Managed by BlackRock, a leading global asset manager.
- Potential for high growth due to sector-specific expertise.
- Global investment reach.
What Are SHSCX's Weaknesses?
Concentrated investment strategy increases risk.
- Performance highly dependent on the health sciences sector.
- No dividend yield may deter income-seeking investors.
- Susceptible to regulatory changes in the healthcare industry.
What Are the Key Risks for SHSCX?
Economic downturn impacting healthcare spending.
- Unfavorable regulatory changes in the healthcare industry.
- Increased competition from other health sciences funds.
- Technological obsolescence in certain healthcare sub-sectors.
- Concentration risk due to focus on the health sciences sector.
What Are SHSCX's Competitive Advantages?
- BlackRock's brand reputation and extensive research capabilities.
- Concentrated focus on the health sciences sector.
- Global investment reach, including non-U.S. companies.
What Does SHSCX Do?
BlackRock Health Sciences Opportunities Portfolio (SHSCX) is a specialized mutual fund managed by BlackRock, Inc., a leading global investment management firm. The fund is designed to provide investors with exposure to the health sciences sector, which encompasses a wide range of industries including healthcare equipment and supplies, healthcare providers and services, biotechnology, and pharmaceuticals. The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies operating within these health-related fields. This concentration allows for a focused investment strategy targeting growth opportunities within the healthcare landscape. The fund may also invest in companies located outside of the United States, providing a global perspective on the health sciences sector. BlackRock, as the manager, brings its extensive research capabilities and investment expertise to the fund, aiming to identify companies with strong growth potential and innovative technologies. The fund's investment decisions are guided by a team of experienced portfolio managers who analyze market trends, assess company financials, and evaluate the competitive landscape within the health sciences industry. The fund's objective is to achieve long-term capital appreciation by investing in a diversified portfolio of health sciences companies. The fund's concentrated approach to the health sciences sector allows it to capitalize on the growth drivers and innovation within the industry, while also managing the inherent risks associated with investing in a specific sector. BlackRock's global presence and research capabilities provide the fund with a competitive advantage in identifying and evaluating investment opportunities in the health sciences sector worldwide.
What Products and Services Does SHSCX Offer?
- Invests primarily in equity securities of health sciences companies.
- Focuses on companies in health care equipment and supplies.
- Targets health care providers and services.
- Includes biotechnology companies in its portfolio.
- Invests in pharmaceutical companies.
- May invest in companies located in non-U.S. countries.
How Does SHSCX Make Money?
- Generates revenue through management fees charged on assets under management (AUM).
- Aims to achieve long-term capital appreciation for investors.
- Concentrates investments in the health sciences sector to capitalize on industry growth.
What Industry Does SHSCX Operate In?
The asset management industry is characterized by intense competition, evolving regulatory landscapes, and increasing demand for specialized investment products. Funds like BlackRock Health Sciences Opportunities Portfolio (SHSCX) cater to investors seeking targeted exposure to specific sectors, such as health sciences. The health sciences sector is experiencing growth driven by factors such as an aging population, technological advancements, and increasing healthcare spending. SHSCX competes with other health sciences-focused funds, such as FSPHX, LMGNX, MUTHX, PRPFX, and RBAIX, as well as broader healthcare ETFs and mutual funds. The fund's success depends on its ability to identify and invest in promising companies within the health sciences sector, while also managing risks associated with sector concentration and market volatility.
Who Are SHSCX's Key Customers?
- Individual investors seeking exposure to the health sciences sector.
- Institutional investors looking for specialized investment strategies.
- Retirement savers seeking long-term growth opportunities.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is a fund, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 42 snapshots
| 2026-08-23 | 46 |
| 2026-08-31 | 46 |
| 2026-09-08 | 46 |
| 2026-09-16 | 46 |
| 2026-09-24 | 46 |
| 2026-10-04 | 46 |
| 2026-10-05 | 46 |
What changed?
The score has stayed at 46.
Over the same 30 days the stock moved -3.1%.
SHSCX Financials
Bull Case vs Bear Case
Bull Case
- Strong focus on the health sciences sector.
- Managed by BlackRock, a leading global asset manager.
- Potential for high growth due to sector-specific expertise.
- Global investment reach.
Bear Case
- Concentrated investment strategy increases risk.
- Performance highly dependent on the health sciences sector.
- No dividend yield may deter income-seeking investors.
- Susceptible to regulatory changes in the healthcare industry.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
SHSCX Latest News
No recent news available for SHSCX.
SHSCX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for SHSCX.
Price Targets
Wall Street price target analysis for SHSCX.
SHSCX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for SHSCX; grades run from A+ (80-100) to F (below 30).
BlackRock Health Sciences Opportunities Portfolio Financials Stock: Key Questions Answered
What are the main risks for SHSCX?
The main risks for BlackRock Health Sciences Opportunities Portfolio (SHSCX) include sector concentration risk, as the fund's performance is highly dependent on the health sciences industry.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Reliance on provided data for factual accuracy.